Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
The relationship between interleukin-1 receptor antagonist polymorphism and tuberculosis disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Genetic polymorphism in the human tumor necrosis factor (TNF ) and its association with different clinical types of tuberculosis disease in Peruvian patients Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
Allelic polymorphism of IL-4 and IL-10 genes as underlying factor in the production of cytokines and rate of recurrent pulmonary tuberculosis(RPTB) Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Investigation of vitamin D receptor gene variants in Iranian patients affected with pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005
Toll-like receptor (TLR) 2 promotor polymorphism is associated with the disease course in sarcoidosis patients Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006
Lack of association between interferon-gamma receptor-1 polymorphism and pulmonary tuberculosis in Iranian population sample Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
The associations between an IL-2 gene polymorphism and smoking in patients with recurrent pulmonary tuberculosis (RTB) Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics Year: 2018
Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Expression levels of membrane-bound tumor necrosis factor alpha receptors in active tuberculosis and healthy individuals Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Interferon gamma (IFN?) pathway deficiency and severe NTM disease Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease Source: Eur Respir J 2004; 23: 219-223 Year: 2004
Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease Source: Eur Respir J 2007; 30: 736-742 Year: 2007
Interferon-γ gene polymorphisms on interferon-γ production affects susceptibility and treatment response to tuberculosis in Japanese populationSource: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Features of cytokine production, subpopulation structure of lymphocytes and functional state of neutrophils in patients with disseminated MDR tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006
Toll-like receptor polymorphisms associated with progression of Mycobacterium tuberculosis infection to pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006